Applications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor Cancers
Efforts Are Underway to Move CRISPR/Cas9 from Bench to Bedside
Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
Flip the DNA Nanoswitch, Power the Clinical App
A Molecular Interaction Detection Platform Uses a Gel-based Readout
Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
For full access to this article login to GEN Select now.
Cell-Free DNA Drives Liquid Biopsy Testing
Researchers Are Diligently Finding Ways to Use Scraps of cfDNA in Clinically Relevant Ways
- Capturing and identifying circulating DNA could hold the key to rapid, minimally invasive, disease diagnostics—ultimately improving clinical decision making and outcomes. [oonal / Getty Images]
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.